Metabolic Disorders
33
5
7
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
3 terminated out of 33 trials
75.0%
-11.5% vs benchmark
6%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (33)
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
Effect of NAE on Polycystic Ovarian Syndrome (PCOS)
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
A Natural History Study of Metabolic Sizing in Health and Disease
Diet and WB-EMS Effects in Obesity
Hormonal and Microbiota Modulation After Endoscopic Sleeve Gastroplasty
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes
Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.
China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort)
Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders
Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
Chinese Migrant Population Health Cohort
Interactive Roles of Cardiorespiratory Fitness and Adiposity on Glucose and Vascular Control After Physical Inactivity
An Optimized Programming of Healthy Children (APPROACH)
Exploring Physical Exercise for the Regulation and Control of Metabolic Disorders in College Students.
Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders
Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases